12 days ago
VRDN
AnalystsDerek ArchilaDerek Archila's Stock Forecasts
AnalystsDerek Archila
Analyst Ranking
Top 2%
#77 out of 5319 analysts
Average Return
+32.06%
Win Rate
68%131 out of 193
Risk vs Reward
Poor
Good
Derek Archila's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +1,563.62% | $0.87 | $14.54 | 2022-09-14 - 2023-09-13 | Strong Buy |
Alumis IncALMS | +629.64% | $3.88 | $28.31 | 2025-07-25 - 2026-07-10 | Strong Buy |
Prometheus Biosciences IncRXDX | +604.58% | $27.52 | $193.90 | 2022-05-13 - 2023-05-12 | Strong Buy |
Prometheus Biosciences IncRXDX | +294.01% | $50.74 | $199.92 | 2022-08-29 - 2023-06-15 | Strong Buy |
Anaptysbio IncANAB | +204.79% | $15.02 | $45.78 | 2024-12-12 - 2025-12-11 | Strong Buy |
Derek Archila Analyst Color
Get additional color on Derek Archila's coverage of popular stocks
a month ago
RYTM
a month ago
ARGX
2 months ago
ALMS
2 months ago
CLDX
2 months ago
ARGX
4 months ago
RYTM
4 months ago
IRON
5 months ago
IRON
6 months ago
ARGX
6 months ago
SLNO
6 months ago
RYTM
6 months ago
BBIO
6 months ago
ASND
6 months ago
ASND
6 months ago
ALMS
7 months ago
KYTX
7 months ago
GLUE
7 months ago
KYMR
7 months ago
ORIC
7 months ago
INCY
8 months ago
ANNX
8 months ago
SEPN
8 months ago
BBIO
8 months ago
KYTX
Derek Archila's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $11.00 | +149.43% | Initiates Coverage On | a day ago |
Viridian Therapeutics IncVRDN | 5 | Strong Buy | $31.00 | +57.04% | Upgrades | 12 days ago |
Rhythm Pharmaceuticals IncRYTM | 11 | Strong Buy | $155.00 | +42.99% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 10 | Strong Buy | $25.00 | +8.41% | Maintains | a month ago |
First Tracks Biotherapeutics IncTRAX | 1 | Strong Buy | $30.00 | -17.22% | Initiates Coverage On | a month ago |
Argenx SeARGX | 18 | Strong Buy | $1,291.00 | +47.10% | Maintains | a month ago |
Cabaletta Bio IncCABA | 12 | Hold | $4.00 | +34.45% | Maintains | 2 months ago |
Alumis IncALMS | 3 | Strong Buy | $51.00 | +80.15% | Maintains | 2 months ago |
Celldex Therapeutics IncCLDX | 5 | Strong Buy | $54.00 | +38.07% | Maintains | 2 months ago |
Ascendis Pharma AASND | 16 | Strong Buy | $326.00 | +20.54% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 3 | Hold | $377.00 | +26.19% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 14 | Hold | $41.00 | -0.07% | Downgrades | 3 months ago |
Soleno Therapeutics IncSLNO | 5 | Hold | $53.00 | -0.02% | Downgrades | 3 months ago |
Alx Oncology Holdings IncALXO | 1 | Strong Buy | $5.00 | +135.29% | Initiates Coverage On | 4 months ago |
Monte Rosa Therapeutics IncGLUE | 10 | Strong Buy | $29.00 | +25.87% | Maintains | 4 months ago |
Septerna IncSEPN | 6 | Strong Buy | $48.00 | +33.59% | Maintains | 4 months ago |
Disc Medicine IncIRON | 3 | Strong Buy | $79.00 | +3.15% | Maintains | 4 months ago |
Bridgebio Pharma IncBBIO | 3 | Strong Buy | $98.00 | +14.10% | Maintains | 5 months ago |
Incyte CorpINCY | 13 | Hold | $101.00 | -13.46% | Maintains | 5 months ago |
Ventyx Biosciences IncVTYX | 6 | Hold | $14.00 | 0.00% | Downgrades | 6 months ago |
Kyverna Therapeutics IncKYTX | 4 | Strong Buy | $33.00 | +288.92% | Maintains | 7 months ago |
Kymera Therapeutics IncKYMR | 10 | Strong Buy | $116.00 | -2.81% | Maintains | 7 months ago |
Oric Pharmaceuticals IncORIC | 2 | Strong Buy | $25.00 | +130.41% | Maintains | 7 months ago |
Annexon IncANNX | 4 | Strong Buy | $27.00 | +365.52% | Maintains | 8 months ago |
Arvinas IncARVN | 8 | Strong Buy | $15.00 | +81.38% | Maintains | 8 months ago |
Anaptysbio IncANAB | 4 | Strong Buy | $81.00 | +22.01% | Maintains | 8 months ago |
Exelixis IncEXEL | 4 | Hold | $30.00 | -46.90% | Maintains | 9 months ago |
Kezar Life Sciences IncKZR | 11 | Hold | $5.00 | -31.41% | Maintains | 9 months ago |
C4 Therapeutics IncCCCC | 6 | Strong Buy | $10.00 | +146.31% | Maintains | 10 months ago |
Atyr Pharma IncATYR | 3 | Hold | $1.00 | +83.82% | Downgrades | 10 months ago |
Sutro Biopharma IncSTRO | 1 | Hold | $30.00 | +0.91% | Maintains | a year ago |
Zentalis Pharmaceuticals IncZNTL | 5 | Hold | $5.00 | +2.46% | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 8 | Hold | $129.00 | N/A | Downgrades | a year ago |
Q32 Bio IncQTTB | 2 | Hold | $15.00 | N/A | Maintains | a year ago |
Zymeworks IncZYME | 5 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Immunovant IncIMVT | 9 | Strong Buy | $45.00 | N/A | Maintains | 2 years ago |
Acelyrin IncSLRN | 5 | Strong Buy | $13.00 | N/A | Maintains | 2 years ago |
Morphosys AgMOR | 4 | Hold | $18.25 | N/A | Downgrades | 2 years ago |
Dice Therapeutics IncDICE | 2 | Hold | $48.00 | N/A | Maintains | 3 years ago |
Morphic Holding IncMORF | 5 | Strong Buy | $80.00 | N/A | Maintains | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Hold | $116.50 | N/A | Downgrades | 4 years ago |
Prometheus Biosciences IncRXDX | 4 | Strong Buy | $71.00 | N/A | Maintains | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $71.00 | N/A | Initiates Coverage On | 5 years ago |
Esperion Therapeutics IncESPR | 1 | Hold | $20.00 | N/A | Downgrades | 5 years ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $24.00 | N/A | Upgrades | 5 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Hold | $52.50 | N/A | Downgrades | 6 years ago |
Principia Biopharma IncPRNB | 1 | Hold | $100.00 | N/A | Downgrades | 6 years ago |
Inventiva SaIVA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 6 years ago |
Genfit SaGNFTY | 1 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Lakefront Biotherapeutics NvLKFT | 1 | Hold | $193.00 | N/A | Downgrades | 6 years ago |
Viela Bio IncVIE | 1 | Hold | $58.00 | N/A | Initiates Coverage On | 6 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $8.00 | N/A | Upgrades | 6 years ago |
Oneok IncOKE | 1 | Strong Buy | $41.00 | N/A | Reiterates | 6 years ago |
Amarin Corp PLCAMRN | 3 | Hold | $160.00 | N/A | Maintains | 6 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $32.00 | N/A | Maintains | 6 years ago |
Dbv Technologies SaDBVT | 3 | Hold | $60.00 | N/A | Downgrades | 6 years ago |
Vanda Pharmaceuticals IncVNDA | 4 | Hold | $29.00 | N/A | Downgrades | 8 years ago |
Heron Therapeutics IncHRTX | 2 | Buy | $50.00 | N/A | Maintains | 8 years ago |
Urogen Pharma LtdURGN | 1 | Buy | $51.00 | N/A | Maintains | 9 years ago |
Perrigo Co PLCPRGO | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 9 years ago |
Pacira Biosciences IncPCRX | 1 | Hold | N/A | N/A | Initiates Coverage On | 9 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.